Myelodysplastic syndromes (MDS) with a deletion 5q display a specific immunophenotypic profile

被引：0
|
作者：
Oelschlaegel, U. [1 ]
Westers, T. M. [2 ]
Mohr, B. [1 ]
Parmentier, S. [1 ]
Sockel, K. [1 ]
Bornhaeuser, M. [1 ]
Van de Loosdrecht, A. A. [2 ]
Platzbecker, U. [1 ]
机构：
[1] Univ Hosp Dresden, Med Clin & Policlin 1, Dresden, Germany
[2] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Hematol, Amsterdam, Netherlands
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70106-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-057
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [41] Deregulation of innate immune signaling in myelodysplastic syndromes is associated with deletion of chromosome arm 5q
    Starczynowski, Daniel T.
    Karsan, Aly
    CELL CYCLE, 2010, 9 (05) : 855 - 856
  • [42] Frequency and Clinical Impact of Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5q)
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Sarova, Iveta
    Lizcova, Libuse
    Izakova, Silvia
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Berkova, Adela
    Skipalova, Karolina
    Belickova, Monika
    Siskova, Magda
    Neuwirtova, Radana
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    BLOOD, 2016, 128 (22)
  • [43] Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter?
    Gorshein, Elan
    Weber, Urs M.
    Gore, Steven
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (03) : 233 - 239
  • [44] A decade of progress in myelodysplastic syndrome with chromosome 5q deletion
    Alan List
    Benjamin L. Ebert
    Pierre Fenaux
    Leukemia, 2018, 32 : 1493 - 1499
  • [45] Tetraploidy and 5q deletion in myelodysplastic syndrome: A case report
    Znoyko, Iya
    Stuart, Robert K.
    Ellingham, Tara
    Winters, Jennifer
    Wolff, Daynna J.
    Quigley, Denise I.
    CANCER GENETICS AND CYTOGENETICS, 2008, 183 (01) : 64 - 68
  • [46] Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy
    Prebet, Thomas
    Toma, Andrea
    Cluzeau, Thomas
    Sekeres, Mikkael A.
    Vey, Norbert
    Park, Sophie
    Al Ali, Najla
    Sugrue, Marie M.
    Komrokji, Rami
    Fenaux, Pierre
    Gore, Steven D.
    ONCOTARGET, 2017, 8 (23) : 37866 - 37874
  • [47] Clinicopathological characteristics of myelodysplastic syndromes with del(5q) in Taiwan
    Yang, Ching -Fen
    Hsu, Chih-Yi
    Hsiao, Liang-Tsai
    Chen, Shang -Wen
    Chuang, Shih-Sung
    MALAYSIAN JOURNAL OF PATHOLOGY, 2023, 45 (03) : 405 - 416
  • [48] Blood consult: treating del(5q) myelodysplastic syndromes
    Mukherjee, Sudipto
    Tiu, Ramon V.
    Sekeres, Mikkael A.
    BLOOD, 2012, 119 (02) : 342 - 344
  • [49] Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion
    Steensma, David P.
    Ebert, Benjamin L.
    BLOOD, 2013, 121 (21) : 4428 - 4428
  • [50] 5q Deletion Myelodysplastic Syndrome a Young Male Patient
    Elkattawy, Sherif
    Ayad, Sarah
    El-Feki, Iman
    Guo, Xutong
    Appiah-Kubi, Edmund
    Talpur, Afrah
    Kessler, William
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
12345